Evergreen Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.4M Sell
258,518
-3,779
-1% -$442K 0.59% 32
2026
Q1
$31.8M Buy
262,297
+6,205
+2% +$716K 0.69% 25
2025
Q4
$27.2M Sell
256,092
-1,293
-0.5% -$121K 0.61% 31
2025
Q3
$21.8M Buy
257,385
+341
+0.1% +$28.1K 0.52% 42
2025
Q2
$20.6M Buy
257,044
+97,485
+61% +$7.75M 0.62% 32
2025
Q1
$14.4M Buy
159,559
+48,179
+43% +$4.5M 0.49% 49
2024
Q4
$11.2M Buy
111,380
+41,947
+60% +$4.32M 0.36% 76
2024
Q3
$7.94M Sell
69,433
-4,649
-6% -$552K 0.27% 108
2024
Q2
$9.23M Buy
74,082
+1,352
+2% +$174K 0.33% 84
2024
Q1
$9.65M Sell
72,730
-501
-0.7% -$61.8K 0.36% 73
2023
Q4
$8.04M Buy
73,231
+5,808
+9% +$603K 0.33% 89
2023
Q3
$6.99M Sell
67,423
-913
-1% -$98.4K 0.31% 97
2023
Q2
$7.93M Buy
68,336
+2,661
+4% +$302K 0.33% 87
2023
Q1
$7.03M Buy
65,675
+1,169
+2% +$126K 0.32% 92
2022
Q4
$7.2M Sell
64,506
-780
-1% -$79.7K 0.34% 85
2022
Q3
$5.66M Buy
65,286
+6,730
+11% +$601K 0.3% 100
2022
Q2
$5.37M Sell
58,556
-24,755
-30% -$2.19M 0.28% 105
2022
Q1
$6.84M Buy
83,311
+283
+0.3% +$22.3K 0.28% 104
2021
Q4
$6.36M Buy
83,028
+4,588
+6% +$365K 0.25% 110
2021
Q3
$5.89M Buy
78,440
+2,926
+4% +$223K 0.27% 100
2021
Q2
$5.87M Sell
75,514
-5,946
-7% -$442K 0.28% 96
2021
Q1
$5.99M Sell
81,460
-3,065
-4% -$226K 0.31% 91
2020
Q4
$6.6M Buy
84,525
+1,991
+2% +$152K 0.39% 69
2020
Q3
$6.53M Buy
82,534
+1,935
+2% +$152K 0.45% 56
2020
Q2
$5.95M Buy
80,599
+4,445
+6% +$335K 0.45% 58
2020
Q1
$5.59M Buy
76,154
+16,387
+27% +$1.29M 0.52% 51
2019
Q4
$5.19M Buy
59,767
+999
+2% +$82.1K 0.43% 58
2019
Q3
$4.72M Buy
58,768
+848
+1% +$68K 0.44% 60
2019
Q2
$4.63M Buy
57,920
+2,186
+4% +$167K 0.44% 58
2019
Q1
$4.42M Sell
55,734
-11,460
-17% -$857K 0.44% 56
2018
Q4
$4.9M Sell
67,194
-9,418
-12% -$665K 0.51% 50
2018
Q3
$5.19M Sell
76,612
-1,258
-2% -$80.1K 0.46% 54
2018
Q2
$4.51M Buy
77,870
+3,683
+5% +$208K 0.42% 55
2018
Q1
$3.86M Buy
74,187
+55,899
+306% +$3.02M 0.37% 68
2017
Q4
$982K Sell
18,288
-9,761
-35% -$541K 0.1% 135
2017
Q3
$1.71M Buy
28,049
+23,716
+547% +$1.44M 0.2% 98
2017
Q2
$265K Buy
+4,333
New +$264K 0.04% 121
2017
Q1
Sell
-4,287
Closed -$240K 108
2016
Q4
$240K Hold
4,287
0.05% 106
2016
Q3
$255K Buy
4,287
+530
+14% +$31K 0.05% 99
2016
Q2
$207K Buy
+3,757
New +$200K 0.05% 94

Other funds holding MRK

Evergreen Capital Management's MRK Position: Q2 2026 in Review

Evergreen Capital Management reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $442K and leaving 258,518 shares worth $33.4M. The position accounts for 0.59% of the portfolio, ranked #32.

Evergreen Capital Management first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Evergreen Capital Management held 258,518 shares of Merck worth $33.4M as of Q2 2026.
  • Evergreen Capital Management sold 3,779 Merck shares in Q2 2026, an estimated $442K.
  • Merck made up 0.59% of Evergreen Capital Management's portfolio in Q2 2026, its #32 holding.
  • Evergreen Capital Management first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.